← Eichor
Condition: Diuresis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Diuresis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING
Phase N/A · 1 location(s) · Sindh Institute of Urology and Transplantation · NCT07570771Comparison of Urinary Flow Study
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06918067Natriuresis-guided Depletion After Cardiac Surgery
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07077772Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2 · 1 location(s) · Anahita Rabiee MD MHS · NCT06812390Bumetanide vs. Furosemide in Cirrhosis
Phase 3 · 1 location(s) · Stacy Johnson · NCT06941415Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
Phase 4 · 1 location(s) · Fundación para la Investigación del Hospital Clínico de Vale · NCT06578520Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones Wit
Phase 3 · 9 location(s) · University Hospital, Tours · NCT05916963POCUS-Guided Diuresis for Decompensated Heart Failure
NA · 5 location(s) · University of Pittsburgh · NCT06921603Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)
Phase N/A · 1 location(s) · Puerta de Hierro University Hospital · NCT06285760
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.